hämostaseologie
130090;130265;140300
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Hämostaseologie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
Aims and Scope
Editorial Board
German National License
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Collections
HAMO Women
About Women in Medicine
Open Access
GTH
GTH News
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
Issues
Current Issue
Free Sample Issue (01/2023)
Related Journals
Thrombosis and Haemostasis
International Journal of Angiology
Seminars in Thrombosis and Hemostasis
The Thoracic and Cardiovascular Surgeon
The Thoracic and Cardiovascular Surgeon Reports
TH Open
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Y
Z
Ú
Ć
Š
Machacek, J
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Magnacca, S
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Magnenat, S
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Mahlangu, J
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Maître, B
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Malek, N
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Manceau, JF
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Mancuso, ME
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Mangels, L
Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
Mangin, P
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Marconi, C
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Margetić, S
Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports
Margraf, A
Examination of the Rac-modulator ArhGAP15 in platelet activation.
Thrombopoietin levels in sepsis and septic shock - a meta-analysis.
Marini, I
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Marinoni, M
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Maro, G
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Marten, S
Laboratory phenotype variability in genetically proven von Willebrand disease type 2B
Martin, A
Evaluation of different processing methods to label platelets for in vivo studies
Martinez, R
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Marzollo, A
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Massberg, S
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Masszi, T
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Matzdorff, A
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
May, M
Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany
Mbemba, E
Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.
Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
Mege, D
Evolution of platelet phenotype during SARS-CoV-2 infection
Mege, JL
Evolution of platelet phenotype during SARS-CoV-2 infection
Mehic, D
Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Mehrländer, M
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Mei, B
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Meier, O
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Meijer, K
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Meinel, K
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Meisel, H
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Meißner, V
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Meister, S
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Mendez, A
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Menne, J
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Merrelaar, A
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Metz, LM
Phosphorylation and activation of Pannexin-1 upon platelet activation and thrombus formation
Meyer, O
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
Mező, B
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Miesbach, W
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Miesbach, WA
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Mischnik, M
Characterization of rFIX fusion proteins enabling subcutaneous administration
Mischung, C
Noonon syndrome as unlikely cause of increased bruising in a case of suspected battered child syndrome
Mitchell, IS
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Mohebi, D
Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany
Möhnle, P
A novel approach to laboratory assessment of platelet von Willebrand factor
Mohr, G
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay
Mojzisch, A
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Mondorf, W
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Moradpour, D
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Morange, PE
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Evolution of platelet phenotype during SARS-CoV-2 infection
Morel-Kopp, MC
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Mourey, G
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Mouriaux, C
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Mueller, T
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Mukhin, N
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Müller, B
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Müller, J
Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway
Müller, V
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Müller-Plettenberg, B
Safety and efficacy of a high-purity plasma derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for joint bleeding: results from a post-marketing study
Safety and efficacy of a high-purity plasma-derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for gastrointestinal bleeding: results from a post-marketing study
Mullier, F
Prothrombotic Disturbances of Hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Study
Muret, C
Evaluation of different processing methods to label platelets for in vivo studies